Direct intravenous injection of ivlv-X1 lentiviral vector for x-linked combined immunodeficiency diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jul 2017: Trial registered, NCT03217617

The trials

NCT03217617: SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection

State
Not started
Phase
Phase 1 and Phase 2
People
10 planned
Started
30 Jun 2027
Primary completion
31 Dec 2028
Arms
Single arm
Results
None posted
  1. 14 Jul 2017: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.